[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 11, 1965

Package Inserts of Drugs —Related Problems

Author Affiliations

Maplewood, NJ

JAMA. 1965;194(2):207-209. doi:10.1001/jama.1965.03090150099033

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  As a practicing cardiologist and internist I would bring to your attention the plight of the practicing physician faced with the new regulations of the Food and Drug Administration. Everyone is crying for the drug manufacturers and their problems, but nobody seems to remember that the physician has been more affected by these rules and regulations than anybody else.My particular point of concern is with the drug package insert and the huge mass of material it contains in small type. If I were to read to the patient the list of the things he should watch for, and report at once to me, the impact would so frighten him that the drug would lose all its value, even if it could have been effective. More often, he would be too frightened even to take the drug.It would be necessary with most of the drugs that

First Page Preview View Large
First page PDF preview
First page PDF preview